Dr. Florian Krammer

Ep. 26: “Viruses and Glycoproteins” Featuring Dr. Florian Krammer Blog Post

Dr. Florian Krammer is a Professor of Vaccinology at Icahn School of Medicine at Mount Sinai. His lab focuses on understanding broadly-reactive immune responses against the surface glycoproteins of RNA viruses such as influenza, with the goal to develop better vaccines and novel therapeutics. He talks about his lab’s shift to COVID-19 research, strategies for vaccine development, and how we can prepare for future pandemics.

Andy Kokaji and Hannah Lee

Ep. 25: “Immunology and Industry” Featuring Drs. Andy Kokaji and Hannah Lee Blog Post

Dr. Andy Kokaji is a Senior Director of Immunology, and Dr. Hannah Lee is a Senior Director of Product Management, at STEMCELL Technologies. They discuss their career paths and how they develop and commercialize products to support scientists worldwide.

Hannah Lee and Andy Kokaji square

Drs. Hannah Lee & Andy Kokaji

Dr. Hannah Lee is a Senior Director of Product Management, and Dr. Andy Kokaji is a Senior Director of Immunology at STEMCELL Technologies, a company that provides high-quality cell culture…

Michael Rosenblum

Dr. Michael Rosenblum

Dr. Michael Rosenblum is a Professor of Dermatology at the University of California, San Francisco. The central focus of his lab’s research is to understand how immune responses are regulated…

Jen Gommerman

Ep. 24: “Autoimmune Disease” Featuring Dr. Jennifer Gommerman Blog Post

Dr. Jennifer Gommerman is a Professor of Immunology at the University of Toronto. Her team has uncovered a novel gut-brain axis that regulates neuroinflammation and is examining the role of B lymphocytes in Multiple Sclerosis (MS) patients and in animal models of MS. More recently, she has been studying the antibody response to SARS-CoV-2 in saliva samples from patients with COVID-19. She talks about the role of gut-derived plasma cells in multiple sclerosis, and how salivary immunoglobulin A can protect against breakthrough COVID-19 infections.